跳至主要内容
临床试验/NCT01384695
NCT01384695终止早期 1 期

A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia - Project 1

Anandasabapathy, Sharmila, M.D.1 个研究点 分布在 1 个国家目标入组 67 人开始时间: 2009年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
终止
发起方
入组人数
67
试验地点
1
主要终点
to determine whether tissue is neoplastic or non-neoplastic

研究概览

简要总结

The overall objective of this study is to obtain data to evaluate whether high-resolution imaging of the gastrointestinal mucosain vivo can assist clinicians in detecting dysplastic (precancerous) areas. This is an exploratory study of a confocal endoscope designed to evaluate the feasibility of using this FDA-approved device in the endoscopic surveillance of subjects at high-risk for neoplasia in the upper and lower GI tract. The confocal endoscope provides real-time in vivo microscopic images of the mucosa which resemble standard pathology.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient 18 years or older
  • colonoscopy for screening or surveillance of polyps or disease of colon
  • anoscopy because of suspected or known anal dysplasia or neoplasia

排除标准

  • patient unable to provide informed consent
  • patient found unfit for standard colonoscopy or anoscopy with biopsies

研究组 & 干预措施

Fluorescein

Experimental

Confocal imaging using contrast agent fluorescein

干预措施: Proflavine hemisulfate (Drug)

Proflavine hemisulfate

Experimental

confocal imaging using contrast agent proflavine

干预措施: Fluorescein (Drug)

结局指标

主要结局

to determine whether tissue is neoplastic or non-neoplastic

时间窗: 1 day

次要结局

未报告次要终点

研究者

发起方
Anandasabapathy, Sharmila, M.D.
申办方类型
Indiv
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验